What is Project ECHO^®?

ECHO, which stands for Extension for Community Healthcare Outcomes, is an all-teach-all-learn tele-mentoring model that uses case-based learning. Specialists and experts at a “Hub” meet regularly with physicians, nurse practitioners and other clinicians at “Spokes” via videoconferencing to support in the delivery of specialty care services. To learn more about the ECHO model and its history, watch this short video by Project ECHO’s founder, Dr. Sanjeev Arora and visit echo.unm.edu.

ECHO MOLST + eMOLST

ECHO MOLST + eMOLST was developed to meet the ever-increasing demand for professional training and technical assistance for practice transformation focused on advance care planning, MOLST and eMOLST. Project ECHO’s innovative approach will support the current and future needs of our clinicians and system leaders.

The aims of ECHO MOLST + eMOLST are to provide sustainable MOLST education and to improve the quality of thoughtful MOLST discussions and documentation to ensure patient preferences are honored at end-of-life, especially in light of the COVID-19 pandemic. Excellus BlueCross BlueShield is a partner with Project ECHO.

ECHO MOLST + eMOLST is a 9-week clinic series.  Weekly lunch hour-video conferencing clinics begin with brief introductions and a 15-minute didactic presentation given by a MOLST subject matter expert. This is followed by a 35 to 40-minute real patient case presentation given by a “spoke” using a Q&A and discussion format.

Who Should Attend?

ECHO MOLST + eMOLST is open to physicians, nurse practitioners, physician assistants, nurses, social workers and anyone involved in the MOLST process – clinics are open to all!

How to Attend

Participants will connect through the Zoom video conferencing platform. For more information or to sign up, contact Meg.Greco@Excellus.com.

Upon Completion of the 9-week ECHO MOLST + eMOLST Clinic Series, Participants Will:

• Recognize the professional accountability for medical orders on the MOLST and ensure other members of their team work within scope of practice
• Use MOLST for the appropriate patient population
• Describe the differences between standard medical care, advance directives and MOLST
• Utilize a standardized 8-Step MOLST protocol to ensure accurate completion of the MOLST form
• Improve their comfort level with end-of-life conversations
• Ensure an adequate palliative care plan to support MOLST orders
• Recognize that end-of-life conversations are part of professionalism and need to occur in all settings
• Describe the benefits of eMOLST in terms of quality and patient safety
• Manage correct usage of the eMOLST system and administrative functions

ECHO MOLST + eMOLST Didactic Presentations

Additional Resources

• View the ECHO MOLST +  eMOLST Flyer
• For more information or to enroll in the next ECHO MOLST +  eMOLST clinic series, contact Meg Greco at Meg.Greco@Excellus.com.

Endorsements

The Nurse Practitioner Association New York State

New York State Society of Physician Assistants

IPRO

AMA Designation Statement
Project ECHO^® designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC Designation Statement
Project ECHO^® designates this live activity for a maximum of 1.0 ANCC contact hours.  Nursing contact hours will be awarded for successful completion of program components based upon documented attendance and completion of evaluation

Disclosure Statement

Project ECHO®, in compliance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, requires that anyone who is in a position to control the content of an educational activity disclose all relevant financial relationships they have had within the last 24 months with an ineligible company.

None of the planners and presenters for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Patricia Bomba, MD, MACP, FRCP; Katie Orem, MPH; Meg Greco, MPA; Sara Butterfield, RN, BSN, CPHQ, CCM; Carolyn Kazdan, MHSA, NHA; Lynn Wilson, MSW, Christine Segel, RN, MSN, CPHQ and Fred Ratto, BA, CPH